These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 822687)
1. Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero. Seip M Acta Paediatr Scand; 1976 Sep; 65(5):617-21. PubMed ID: 822687 [TBL] [Abstract][Full Text] [Related]
2. Fetal hydantoin syndrome in triplets. A unique experiment of nature. Bustamante SA; Stumpff LC Am J Dis Child; 1978 Oct; 132(10):978-9. PubMed ID: 717308 [TBL] [Abstract][Full Text] [Related]
3. [Fetal hydantoin syndrome in siblings]. Schinzel A Schweiz Med Wochenschr; 1979 Jan; 109(3):68-72. PubMed ID: 104383 [TBL] [Abstract][Full Text] [Related]
4. Fetal malformation due to phenobarbitone. A case report. Berkowitz FE S Afr Med J; 1979 Jan; 55(3):100-1. PubMed ID: 424928 [TBL] [Abstract][Full Text] [Related]
5. [Hypoplasia of the nails and end phalanges as a sequela of prenatal barbiturate exposure]. Holder M; Majewski F; Lenard HG Monatsschr Kinderheilkd; 1990 Jan; 138(1):34-5. PubMed ID: 2107397 [TBL] [Abstract][Full Text] [Related]
7. [Dysmorphisms and psychomotor retardation in infants of mothers treated with anticonvulsants in pregnancy]. Gaetti MT; Carotti G; Vianelli P; Pellegrini L; Bini PL; Scalseggi V Minerva Pediatr; 1979 Sep; 31(17):1261-6. PubMed ID: 119904 [No Abstract] [Full Text] [Related]
8. Four siblings with similar malformations after exposure to phenytoin and primidone. Krauss CM; Holmes LB; VanLang Q; Keith DA J Pediatr; 1984 Nov; 105(5):750-5. PubMed ID: 6502304 [TBL] [Abstract][Full Text] [Related]
9. Fetal hydantoin syndrome: a case report. Nanda A; Kaur S; Bhakoo ON; Kapoor MM; Kanwar AJ Pediatr Dermatol; 1989 Jun; 6(2):130-3. PubMed ID: 2501774 [TBL] [Abstract][Full Text] [Related]
10. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J; Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295 [TBL] [Abstract][Full Text] [Related]
11. [Children exposed in utero to antiepileptic drugs]. Béthenod M; Frédérich A Pediatrie; 1975; 30(3):227-48. PubMed ID: 1178250 [No Abstract] [Full Text] [Related]
12. Digital hypoplasia and anticonvulsants during gestation: a teratogenic syndrome? Barr M; Poznanski AK; Schmickel RD J Pediatr; 1974 Feb; 84(2):254-6. PubMed ID: 4204190 [No Abstract] [Full Text] [Related]
13. Functional palatal incompetence in the fetal anticonvulsant syndrome. Pearl KN; Dickens S; Latham P Arch Dis Child; 1984 Oct; 59(10):989-90. PubMed ID: 6497436 [TBL] [Abstract][Full Text] [Related]
15. Multiple systemic and periocular malformations associated with the fetal hydantoin syndrome. Wallar PH; Genstler DE; George CC Ann Ophthalmol; 1978 Nov; 10(11):1568-72. PubMed ID: 103474 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic malformations in association with maternal trimethadione therapy. Rosen RC; Lightner ES J Pediatr; 1978 Feb; 92(2):240-4. PubMed ID: 413897 [No Abstract] [Full Text] [Related]
18. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs. Holmes LB; Coull BA; Dorfman J; Rosenberger PB J Pediatr; 2005 Jan; 146(1):118-22. PubMed ID: 15644835 [TBL] [Abstract][Full Text] [Related]
19. The effects of phenytoin on rat development: an animal model system for fetal hydantoin syndrome. Lorente CA; Tassinari MS; Keith DA Teratology; 1981 Oct; 24(2):169-80. PubMed ID: 7199765 [TBL] [Abstract][Full Text] [Related]
20. The teratogenicity of anticonvulsant drugs. Holmes LB; Harvey EA; Coull BA; Huntington KB; Khoshbin S; Hayes AM; Ryan LM N Engl J Med; 2001 Apr; 344(15):1132-8. PubMed ID: 11297704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]